Vise Technologies Inc. Invests $978,000 in Humana Inc. $HUM

Vise Technologies Inc. acquired a new stake in shares of Humana Inc. (NYSE:HUM) in the second quarter, Holdings Channel.com reports. The firm acquired 2,463 shares of the insurance provider’s stock, valued at approximately $978,000.

Several other hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Humana by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after acquiring an additional 106,030 shares during the period. BlackRock Inc. bought a new stake in shares of Humana during the second quarter valued at approximately $4,138,160,000. Capital International Investors raised its stake in shares of Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC lifted its position in Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares during the period. Finally, State Street Corp lifted its position in Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after purchasing an additional 97,211 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Needham & Company LLC began coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. Evercore upgraded shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target for the company in a research note on Wednesday, July 29th. Piper Sandler raised Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective on the stock in a report on Thursday, July 30th. Seaport Research Partners lowered Humana to a “neutral” rating in a research note on Wednesday, May 20th. Finally, Cantor Fitzgerald increased their target price on Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a report on Tuesday, July 7th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $395.22.

Humana Price Performance

Shares of HUM stock opened at $379.22 on Friday. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The stock has a market capitalization of $45.54 billion, a PE ratio of 35.88, a PEG ratio of 2.17 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock’s fifty day moving average is $383.38 and its 200-day moving average is $281.59.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the company earned $6.27 EPS. The firm’s quarterly revenue was up 26.2% on a year-over-year basis. Equities research analysts expect that Humana Inc. will post 9.08 EPS for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.